Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on
Schedule for the Operating Results Press Release, Conference Call / Audio Webcast | |
Q2 Fiscal Year 2024 Results Press Release | |
Q2 Fiscal Year 2024 Conference Call-Live US Toll Free Dial-In Number: International Dial-In Number: Participant Access Code: | 1-888-506-0062 1-973-528-0011 397299 |
Q2 Fiscal Year 2024 Conference Call-Replay US Toll Free Dial-In Number: International Dial-In Number: Participant Access Code: | 1-877-481-4010 1-919-882-2331 49945 |
The audio webcast and replay can be accessed by logging on to the "Investors-Webcasts" section of Palatin's website at http://www.palatin.com or by clicking here.
About Palatin
Palatin is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at www.palatin.com and follow Palatin on Twitter at @PalatinTech.
View original content to download multimedia:https://www.prnewswire.com/news-releases/palatin-to-report-second-quarter-fiscal-year-2024-results-teleconference-and-webcast-to-be-held-on-february-15-2024-302058387.html
SOURCE Palatin Technologies, Inc.